The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Multi-Cancer Detection Blood Test Market Research Report 2024
Synopsis
The Multi-Cancer Detection Blood Test, also known as a liquid biopsy or pan-cancer test, is a type of medical test that aims to detect multiple types of cancer in the body using a blood sample. Unlike traditional cancer screenings that focus on specific cancer types, this test is designed to provide a more comprehensive assessment by detecting various cancer-related biomarkers or genetic alterations present in the bloodstream.
The Multi-Cancer Detection Blood Test holds promise for early cancer detection, as it can potentially identify cancers at an earlier stage when treatment options are more effective and outcomes are better. It may also aid in monitoring cancer patients during treatment and post-treatment to detect recurrence or treatment response.
Global Multi-Cancer Detection Blood Test market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multi-Cancer Detection Blood Test market research.
Key manufacturers engaged in the Multi-Cancer Detection Blood Test industry include Galleri, Amadix, Burning Rock, Exact Sciences, Freenome, AnchorDx, Guardant Health, Foundation Medicine and GENECAST, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Multi-Cancer Detection Blood Test were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Multi-Cancer Detection Blood Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multi-Cancer Detection Blood Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Galleri
Amadix
Burning Rock
Exact Sciences
Freenome
AnchorDx
Guardant Health
Foundation Medicine
GENECAST
Coyne Medical
Laboratory for Advanced Medicine
Singlera Genomics
Segment by Type
ctDNA-Based Tests
Protein Biomarker-Based Tests
Methylation-Based Tests
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Multi-Cancer Detection Blood Test report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The Multi-Cancer Detection Blood Test, also known as a liquid biopsy or pan-cancer test, is a type of medical test that aims to detect multiple types of cancer in the body using a blood sample. Unlike traditional cancer screenings that focus on specific cancer types, this test is designed to provide a more comprehensive assessment by detecting various cancer-related biomarkers or genetic alterations present in the bloodstream.
The Multi-Cancer Detection Blood Test holds promise for early cancer detection, as it can potentially identify cancers at an earlier stage when treatment options are more effective and outcomes are better. It may also aid in monitoring cancer patients during treatment and post-treatment to detect recurrence or treatment response.
Global Multi-Cancer Detection Blood Test market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Multi-Cancer Detection Blood Test market research.
Key manufacturers engaged in the Multi-Cancer Detection Blood Test industry include Galleri, Amadix, Burning Rock, Exact Sciences, Freenome, AnchorDx, Guardant Health, Foundation Medicine and GENECAST, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Multi-Cancer Detection Blood Test were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Multi-Cancer Detection Blood Test market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Multi-Cancer Detection Blood Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Galleri
Amadix
Burning Rock
Exact Sciences
Freenome
AnchorDx
Guardant Health
Foundation Medicine
GENECAST
Coyne Medical
Laboratory for Advanced Medicine
Singlera Genomics
Segment by Type
ctDNA-Based Tests
Protein Biomarker-Based Tests
Methylation-Based Tests
Others
Segment by Application
Hospitals
Diagnostic Laboratories
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Multi-Cancer Detection Blood Test report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Multi-Cancer Detection Blood Test Market Overview
1.1 Product Overview and Scope of Multi-Cancer Detection Blood Test
1.2 Multi-Cancer Detection Blood Test Segment by Type
1.2.1 Global Multi-Cancer Detection Blood Test Market Value Comparison by Type (2023-2029)
1.2.2 ctDNA-Based Tests
1.2.3 Protein Biomarker-Based Tests
1.2.4 Methylation-Based Tests
1.2.5 Others
1.3 Multi-Cancer Detection Blood Test Segment by Application
1.3.1 Global Multi-Cancer Detection Blood Test Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Multi-Cancer Detection Blood Test Market Size Estimates and Forecasts
1.4.1 Global Multi-Cancer Detection Blood Test Revenue 2018-2029
1.4.2 Global Multi-Cancer Detection Blood Test Sales 2018-2029
1.4.3 Global Multi-Cancer Detection Blood Test Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Multi-Cancer Detection Blood Test Market Competition by Manufacturers
2.1 Global Multi-Cancer Detection Blood Test Sales Market Share by Manufacturers (2018-2023)
2.2 Global Multi-Cancer Detection Blood Test Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Multi-Cancer Detection Blood Test Average Price by Manufacturers (2018-2023)
2.4 Global Multi-Cancer Detection Blood Test Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Multi-Cancer Detection Blood Test, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Multi-Cancer Detection Blood Test, Product Type & Application
2.7 Multi-Cancer Detection Blood Test Market Competitive Situation and Trends
2.7.1 Multi-Cancer Detection Blood Test Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Multi-Cancer Detection Blood Test Players Market Share by Revenue
2.7.3 Global Multi-Cancer Detection Blood Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Multi-Cancer Detection Blood Test Retrospective Market Scenario by Region
3.1 Global Multi-Cancer Detection Blood Test Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Multi-Cancer Detection Blood Test Global Multi-Cancer Detection Blood Test Sales by Region: 2018-2029
3.2.1 Global Multi-Cancer Detection Blood Test Sales by Region: 2018-2023
3.2.2 Global Multi-Cancer Detection Blood Test Sales by Region: 2024-2029
3.3 Global Multi-Cancer Detection Blood Test Global Multi-Cancer Detection Blood Test Revenue by Region: 2018-2029
3.3.1 Global Multi-Cancer Detection Blood Test Revenue by Region: 2018-2023
3.3.2 Global Multi-Cancer Detection Blood Test Revenue by Region: 2024-2029
3.4 North America Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.4.1 North America Multi-Cancer Detection Blood Test Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Multi-Cancer Detection Blood Test Sales by Country (2018-2029)
3.4.3 North America Multi-Cancer Detection Blood Test Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.5.1 Europe Multi-Cancer Detection Blood Test Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Multi-Cancer Detection Blood Test Sales by Country (2018-2029)
3.5.3 Europe Multi-Cancer Detection Blood Test Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.6.1 Asia Pacific Multi-Cancer Detection Blood Test Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Multi-Cancer Detection Blood Test Sales by Country (2018-2029)
3.6.3 Asia Pacific Multi-Cancer Detection Blood Test Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.7.1 Latin America Multi-Cancer Detection Blood Test Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Multi-Cancer Detection Blood Test Sales by Country (2018-2029)
3.7.3 Latin America Multi-Cancer Detection Blood Test Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Multi-Cancer Detection Blood Test Market Facts & Figures by Country
3.8.1 Middle East and Africa Multi-Cancer Detection Blood Test Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Multi-Cancer Detection Blood Test Sales by Country (2018-2029)
3.8.3 Middle East and Africa Multi-Cancer Detection Blood Test Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Multi-Cancer Detection Blood Test Sales by Type (2018-2029)
4.1.1 Global Multi-Cancer Detection Blood Test Sales by Type (2018-2023)
4.1.2 Global Multi-Cancer Detection Blood Test Sales by Type (2024-2029)
4.1.3 Global Multi-Cancer Detection Blood Test Sales Market Share by Type (2018-2029)
4.2 Global Multi-Cancer Detection Blood Test Revenue by Type (2018-2029)
4.2.1 Global Multi-Cancer Detection Blood Test Revenue by Type (2018-2023)
4.2.2 Global Multi-Cancer Detection Blood Test Revenue by Type (2024-2029)
4.2.3 Global Multi-Cancer Detection Blood Test Revenue Market Share by Type (2018-2029)
4.3 Global Multi-Cancer Detection Blood Test Price by Type (2018-2029)
5 Segment by Application
5.1 Global Multi-Cancer Detection Blood Test Sales by Application (2018-2029)
5.1.1 Global Multi-Cancer Detection Blood Test Sales by Application (2018-2023)
5.1.2 Global Multi-Cancer Detection Blood Test Sales by Application (2024-2029)
5.1.3 Global Multi-Cancer Detection Blood Test Sales Market Share by Application (2018-2029)
5.2 Global Multi-Cancer Detection Blood Test Revenue by Application (2018-2029)
5.2.1 Global Multi-Cancer Detection Blood Test Revenue by Application (2018-2023)
5.2.2 Global Multi-Cancer Detection Blood Test Revenue by Application (2024-2029)
5.2.3 Global Multi-Cancer Detection Blood Test Revenue Market Share by Application (2018-2029)
5.3 Global Multi-Cancer Detection Blood Test Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Galleri
6.1.1 Galleri Corporation Information
6.1.2 Galleri Description and Business Overview
6.1.3 Galleri Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Galleri Multi-Cancer Detection Blood Test Product Portfolio
6.1.5 Galleri Recent Developments/Updates
6.2 Amadix
6.2.1 Amadix Corporation Information
6.2.2 Amadix Description and Business Overview
6.2.3 Amadix Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Amadix Multi-Cancer Detection Blood Test Product Portfolio
6.2.5 Amadix Recent Developments/Updates
6.3 Burning Rock
6.3.1 Burning Rock Corporation Information
6.3.2 Burning Rock Description and Business Overview
6.3.3 Burning Rock Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Burning Rock Multi-Cancer Detection Blood Test Product Portfolio
6.3.5 Burning Rock Recent Developments/Updates
6.4 Exact Sciences
6.4.1 Exact Sciences Corporation Information
6.4.2 Exact Sciences Description and Business Overview
6.4.3 Exact Sciences Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Exact Sciences Multi-Cancer Detection Blood Test Product Portfolio
6.4.5 Exact Sciences Recent Developments/Updates
6.5 Freenome
6.5.1 Freenome Corporation Information
6.5.2 Freenome Description and Business Overview
6.5.3 Freenome Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Freenome Multi-Cancer Detection Blood Test Product Portfolio
6.5.5 Freenome Recent Developments/Updates
6.6 AnchorDx
6.6.1 AnchorDx Corporation Information
6.6.2 AnchorDx Description and Business Overview
6.6.3 AnchorDx Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AnchorDx Multi-Cancer Detection Blood Test Product Portfolio
6.6.5 AnchorDx Recent Developments/Updates
6.7 Guardant Health
6.6.1 Guardant Health Corporation Information
6.6.2 Guardant Health Description and Business Overview
6.6.3 Guardant Health Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Guardant Health Multi-Cancer Detection Blood Test Product Portfolio
6.7.5 Guardant Health Recent Developments/Updates
6.8 Foundation Medicine
6.8.1 Foundation Medicine Corporation Information
6.8.2 Foundation Medicine Description and Business Overview
6.8.3 Foundation Medicine Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Foundation Medicine Multi-Cancer Detection Blood Test Product Portfolio
6.8.5 Foundation Medicine Recent Developments/Updates
6.9 GENECAST
6.9.1 GENECAST Corporation Information
6.9.2 GENECAST Description and Business Overview
6.9.3 GENECAST Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GENECAST Multi-Cancer Detection Blood Test Product Portfolio
6.9.5 GENECAST Recent Developments/Updates
6.10 Coyne Medical
6.10.1 Coyne Medical Corporation Information
6.10.2 Coyne Medical Description and Business Overview
6.10.3 Coyne Medical Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Coyne Medical Multi-Cancer Detection Blood Test Product Portfolio
6.10.5 Coyne Medical Recent Developments/Updates
6.11 Laboratory for Advanced Medicine
6.11.1 Laboratory for Advanced Medicine Corporation Information
6.11.2 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Description and Business Overview
6.11.3 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Laboratory for Advanced Medicine Multi-Cancer Detection Blood Test Product Portfolio
6.11.5 Laboratory for Advanced Medicine Recent Developments/Updates
6.12 Singlera Genomics
6.12.1 Singlera Genomics Corporation Information
6.12.2 Singlera Genomics Multi-Cancer Detection Blood Test Description and Business Overview
6.12.3 Singlera Genomics Multi-Cancer Detection Blood Test Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Singlera Genomics Multi-Cancer Detection Blood Test Product Portfolio
6.12.5 Singlera Genomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Multi-Cancer Detection Blood Test Industry Chain Analysis
7.2 Multi-Cancer Detection Blood Test Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Multi-Cancer Detection Blood Test Production Mode & Process
7.4 Multi-Cancer Detection Blood Test Sales and Marketing
7.4.1 Multi-Cancer Detection Blood Test Sales Channels
7.4.2 Multi-Cancer Detection Blood Test Distributors
7.5 Multi-Cancer Detection Blood Test Customers
8 Multi-Cancer Detection Blood Test Market Dynamics
8.1 Multi-Cancer Detection Blood Test Industry Trends
8.2 Multi-Cancer Detection Blood Test Market Drivers
8.3 Multi-Cancer Detection Blood Test Market Challenges
8.4 Multi-Cancer Detection Blood Test Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
